Compound Detail
CHEMBL1503
OMEPRAZOLE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL1503 |
| Name | OMEPRAZOLE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | SUBDBMMJDZJVOS-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
| Active Moiety | CHEMBL1201400 |
27
Targets
53
Activities
3
Assay Types
30
PK Parameters
20
Publications
18
Known Names
20
Indications
1
Mechanisms
Molecular Properties
345.4
MW (Da)
2.90
ALogP
5
HBA
1
HBD
83.1
PSA (Ų)
0.72
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1989 |
| Availability | OTC |
| Chirality | Racemic |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Potassium-transporting ATPase inhibitor | INHIBITOR | Potassium-transporting ATPase | ✓ | ✓ |
Indications
Duodenal Ulcer Esophagitis Gastroesophageal Reflux Heartburn Infections Peptic Ulcer Stomach Ulcer Stomach Ulcer Barrett Esophagus Cough Cysticercosis Diabetes Mellitus, Type 1 Dyspepsia Esophagitis, Peptic Exocrine Pancreatic Insufficiency Gastrointestinal Hemorrhage Helicobacter Infections Hemorrhage Multiple Sclerosis, Relapsing-Remitting Osteoarthritis
ATC Classification
A02BC01
omeprazole
Level 1: ALIMENTARY TRACT AND METABOLISM
Level 2: DRUGS FOR ACID RELATED DISORDERS
Activity Summary
IC50 49 meas. best 7.02
EC50 2 meas. best 4.85
Ki 2 meas. best 5.47
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Giardia intestinalis CHEMBL612652 | IC50 | 7.02 | 7.02 | 95.5 | 2 |
| Trichomonas vaginalis CHEMBL612884 | IC50 | 6.92 | 6.92 | 121.6 | 2 |
| Potassium-transporting ATPase CHEMBL2095173 | IC50 | 6.6 | 5.95 | 250.0 | 7 |
| Entamoeba histolytica CHEMBL612853 | IC50 | 6.31 | 6.31 | 492.2 | 1 |
| Plasmodium berghei CHEMBL612653 | IC50 | 6.17 | 6.17 | 680.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 6.01 | 5.144 | 980.0 | 5 |
| Histone-lysine N-methyltransferase 2A/WDR5 CHEMBL3883320 | IC50 | 5.77 | 5.77 | 1700.0 | 1 |
| Cytochrome P450 2C19 CHEMBL3622 | IC50 | 5.68 | 5.1975 | 2080.0 | 4 |
| Induced myeloid leukemia cell differentiation protein Mcl-1 CHEMBL4361 | IC50 | 5.5 | 5.5 | 3144.8 | 1 |
| Fatty acid synthase CHEMBL4158 | Ki | 5.47 | 5.47 | 3400.0 | 1 |
| Potassium-transporting ATPase CHEMBL2095228 | IC50 | 5.42 | 4.86 | 3800.0 | 2 |
| Glutathione S-transferase omega-1 CHEMBL3174 | IC50 | 5.34 | 5.34 | 4600.0 | 1 |
| Plasmodium falciparum CHEMBL364 | IC50 | 4.88 | 4.5 | 13230.0 | 2 |
| Bombesin receptor subtype-3 CHEMBL4080 | EC50 | 4.85 | 4.85 | 14000.0 | 1 |
| NON-PROTEIN TARGET CHEMBL3879801 | IC50 | 4.83 | 4.83 | 14800.0 | 1 |
| SARS-CoV-2 CHEMBL4303835 | EC50 | 4.77 | 4.77 | 17060.0 | 1 |
| ATP-dependent translocase ABCB1 CHEMBL4302 | IC50 | 4.75 | 4.2125 | 17700.0 | 4 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 CHEMBL5393 | IC50 | 4.75 | 4.75 | 17600.0 | 1 |
| N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 CHEMBL6036 | IC50 | 4.7 | 4.7 | 20000.0 | 1 |
| Cytosolic endo-beta-N-acetylglucosaminidase CHEMBL5172 | IC50 | 4.6 | 4.6 | 25000.0 | 1 |
| Fatty acid synthase CHEMBL4158 | IC50 | 4.53 | 4.53 | 29600.0 | 1 |
| Sodium/potassium-transporting ATPase CHEMBL2095186 | IC50 | 4.5 | 4.5 | 31622.8 | 1 |
| Cytochrome P450 2C9 CHEMBL3397 | Ki | 4.35 | 4.35 | 45000.0 | 1 |
| Trypanosoma brucei rhodesiense CHEMBL612348 | IC50 | 4.29 | 4.29 | 51820.0 | 1 |
| Trypanosoma cruzi CHEMBL368 | IC50 | 4.17 | 4.17 | 68320.0 | 1 |
| Bile salt export pump CHEMBL6020 | IC50 | 4.12 | 4.06 | 75000.0 | 2 |
| Cytochrome P450 3A4 CHEMBL340 | IC50 | 4.11 | 4.11 | 77983.0 | 1 |
| Leishmania donovani CHEMBL367 | IC50 | 4.04 | 4.04 | 90900.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 511.0 | ng.hr.mL-1 | Homo sapiens |
| AUC | 1140.0 | ng.hr.mL-1 | Homo sapiens |
| AUC | 1220.0 | ng.hr.mL-1 | Homo sapiens |
| AUC | 3352.0 | ng.hr.mL-1 | Homo sapiens |
| AUC | 2276.0 | ng.hr.mL-1 | Homo sapiens |
| AUC | 1179.0 | ng.hr.mL-1 | Homo sapiens |
| AUC | 3882.52 | ng.hr.mL-1 | Homo sapiens |
| CL | 8.4 | mL.min-1.kg-1 | Homo sapiens |
| CL | 8.3 | mL.min-1.kg-1 | Homo sapiens |
| CL | 8.4 | mL.min-1.kg-1 | Homo sapiens |
| CL | 8.4 | mL.min-1.kg-1 | Homo sapiens |
| CL | 0.035 | mL.min-1.g-1 | Homo sapiens |
| CL | 0.032 | mL.min-1.g-1 | Homo sapiens |
| CL | 0.0077 | mL.min-1.g-1 | Homo sapiens |
| CL | 0.0066 | mL.min-1.g-1 | Homo sapiens |
| CL | 0.0082 | mL.min-1.g-1 | Homo sapiens |
| CL | 0.0071 | mL.min-1.g-1 | Homo sapiens |
| CL | 0.18 | uL/min | Homo sapiens |
| CL | 0.4 | uL/min | Homo sapiens |
| CL | 0.94 | uL/min | Homo sapiens |
| CL | 1.11 | uL/min | Homo sapiens |
| CL | 0.53 | uL/min | Homo sapiens |
| CL | 0.24 | uL/min | Homo sapiens |
| CL | 0.79 | uL/min | Homo sapiens |
| CL | 0.66 | uL/min | Homo sapiens |
| CL | 1.3 | uL/min | Homo sapiens |
| CL | 0.41 | uL/min | Homo sapiens |
| CL | 1.21 | uL/min | Homo sapiens |
| CL | 1.91 | uL/min | Homo sapiens |
| CL | 1.54 | uL/min | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine